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Abstract
The plasma protein fetuin-A/alpha2-HS-glycoprotein (genetic symbol Ahsg) is a systemic inhibitor of extraskeletal
mineralization, which is best underscored by the excessive mineral deposition found in various tissues of fetuin-A deficient
mice on the calcification-prone genetic background DBA/2. Fetuin-A is known to accumulate in the bone matrix thus an
effect of fetuin-A on skeletal mineralization is expected. We examined the bones of fetuin-A deficient mice maintained on
a C57BL/6 genetic background to avoid bone disease secondary to renal calcification. Here, we show that fetuin-A deficient
mice display normal trabecular bone mass in the spine, but increased cortical thickness in the femur. Bone material
properties, as well as mineral and collagen characteristics of cortical bone were unaffected by the absence of fetuin-A. In
contrast, the long bones especially proximal limb bones were severely stunted in fetuin-A deficient mice compared to
wildtype littermates, resulting in increased biomechanical stability of fetuin-A deficient femora in three-point-bending tests.
Elevated backscattered electron signal intensities reflected an increased mineral content in the growth plates of fetuin-A
deficient long bones, corroborating its physiological role as an inhibitor of excessive mineralization in the growth plate
cartilage matrix - a site of vigorous physiological mineralization. We show that in the case of fetuin-A deficiency, active
mineralization inhibition is a necessity for proper long bone growth.
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Introduction
Fetuin-A/alpha2-HS-glycoprotein (genetic symbol Ahsg) is
a 52 kDa glycoprotein member of the type 3 cystatin-family
proteins composed of two N-terminal cystatin protein domains,
and a third C-terminal domain rich in proline [1]. Fetuin-A has
originally been described as the most abundant globulin in fetal
calf serum [2], and was long known as one of the most abundant
non-collagenous proteins [3] highly enriched in the mineralized
bone matrix [4–7]. Fetuin-A has a high affinity mineral binding
site located in the amino-terminal domain D1 enabling it to
inhibit ectopic calcification [8,9] by forming soluble colloidal
nanospheres [8,10]. These colloids are variously termed calci-
protein particles CPPs in analogy to lipoprotein particles [9,11],
or fetuin-mineral complex FMC [10] or nanons [12]. Soluble
protein-mineral complexes containing fetuin-A are regarded as
physiological byproducts of mineral metabolism preventing
pathological calcification at sites of high mineral supersaturation
[13,14]. Complexes of fetuin-A, albumin and calcium phosphate
have been detected serum [15] including human serum of
chronic kidney disease patients [16,17] and in ascites of patients
with peritoneal calcifying sclerosis [18]. These complexes have
been previously implicated as the source of an entity dubbed
‘‘nanobacteria’’ that have vexed the microbiology and biominer-
alization community for almost a decade [12,14,15,19]. Thus the
role of fetuin-A as an important regulator of mineralization or
a ‘‘mineral chaperone’’ [13,20] has gained abundant support, but
its role in mineralization control of the tissue which is most
abundant of it – bone – is understudied. When fetuin-A deficient
mice (Ahsg2/2) became available [21] bone growth and
remodeling phenotypes were examined in these mice. The
skeletal structure of Ahsg2/2 mice appeared normal at birth, but
abnormalities were observed in adult Ahsg2/2 mice. Maturation
of growth plate chondrocytes was impaired, and femurs
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lengthened more slowly between 3 and 18 months of age in
Ahsg2/2 mice. Previously it had been found that fetuin-A is
a soluble transforming growth factor-beta (TGF-beta)/bone
morphogenetic protein (BMP)-binding protein controlling cyto-
kine access to membrane signaling receptors [22,23]. Hence the
altered bone phenotype was explained in terms of failure to block
TGF-beta-dependent signaling in osteoblastic cells. Mice lacking
fetuin-A displayed growth plate defects, increased bone formation
with age, and enhanced cytokine-dependent osteogenesis [24].
Tumorigenesis experiments employing Ahsg2/2 mice further
supported the hypothesis that fetuin-A is an antagonist of
transforming growth factor beta in vivo, in that it inhibited
intestinal tumor progression. All these experiments had been
performed using the first available fetuin-A deficient mouse strain
129,B6Ahsgtm1mbl, which had a mixed 129Sv6C57BL/6 genetic
background [21]. We created two more strains of fetuin-A
deficient mice with defined genetic backgrounds (B6-Ahsgtm1wja,
D2-Ahsgtm1wja) by backcrossing to C57BL/6 and DBA/2 mice.
Surprisingly all D2-Ahsgtm1wja mice showed massive soft tissue
calcification throughout their body, while B6-Ahsgtm1wja mice did
not [25]. The latter mice calcified when additionally challenged
with heminephrectomy and high mineral diet [26,27]. These
results showed that fetuin-A is a systemic, soluble inhibitor of
pathological mineralization that is backed up by other genetic
factors rendering mouse strains prone to or resistant to
dystrophic calcification. Integrative genomics of the so-called
Dyscalc locus led to the identification of Abcc6 as the major causal
gene for dystrophic cardiac calcification [28]. Abcc6 deficient
mice develop soft tissue calcifications that seem to be less
extensive than in D2-Ahsgtm1wja mice both in localization and
extent. Interestingly, Abcc6 deficiency is associated with reduced
plasma fetuin-A levels and the calcifications can be partially
corrected by over-expressing fetuin-A [29] suggesting that fetuin-
A acts downstream or in concert with Abcc6. Despite heavy early
onset and life-long progressing dystrophic calcification in Abcc6
and especially in DBA/2 fetuin-A deficient mice, true osteogen-
esis has never been reported in these mice. This contrasts the
popular view that pathologic calcification is necessarily a form of
ectopic osteogenesis. More likely both genes seem to be involved
in systemic mineral homeostasis and transport. Therefore we
have termed fetuin-A a mineral chaperone mediating the
solubilization, transport and elimination from circulation of
otherwise insoluble mineral much like apolipoproteins help in
lipid transport and metabolism [13,20].
In vitro experiments involving re-mineralization of decalcified
bone tissue showed that in the absence of fetuin-A, extra-fibrillar
mineralization of the collagen fibrils can readily occur, but
proper collagen fibril mineralization cannot [30,31]. Recent
potentiometric titration investigations of fetuin-A mediated
mineralization in solution found resulting mineral in the form
of HAP mineral platelets. We asked if the lack of fetuin-A in
bones of Ahsg2/2 mice would indeed result in altered bone
quality. Here, we report a detailed multiscale analysis of bones
from fetuin-A deficient and fetuin-A producing mice. Surpris-
ingly, contrary to expected differences at the materials level, all
micro-mechanical and micro-structural parameters were found to
be similar in Ahsg2/2 and Ahsg+/+ bone. In sharp contrast,
macro-mechanical strength and bone length were both altered in
Ahsg2/2 mice. This phenotype was associated with enhanced
growth plate cartilage mineralization corroborating the role of
fetuin-A as a blood-borne systemic inhibitor of mineralization
and thus, of pathological calcification in the extracellular and
vascular compartments.
Materials and Methods
Animals and Diets
The animal welfare committee of the Landesamt fu¨r Natur-,
Umwelt- und Verbraucherschutz LANUV of the state of North
Rhine Westfalia approved our animal study protocol. Animal
maintenance and handling was according to the Federation for
Laboratory Animal Science Associations FELASA recommenda-
tions. Animals were sacrificed by isoflurane overdosing. We
studied fetuin-A deficient mice (B6-Ahsgtm1wja, N11 backcross
generation) and wildtype littermates. Mice were maintained in
a temperature-controlled room on a 12-hour day/night cycle.
Food and water were given ad libitum. Fetuin-A deficient
Ahsg2/2 mice on a pure C57BL/6 genetic background were
analyzed using adult mice with ages between 4 and 12 months
for histological and microstructural analyses.
Histomorphometry and mechanical testing- After the initial analysis by
contact X-ray (Faxitron Xray Corp., Lincolnshire, USA) the
vertebral bodies L2 to L5 were dehydrated and embedded non-
decalcified into polymethylmetacrylate (PMMA) for sectioning.
Sections were either stained with toluidine blue or by the von
Kossa/van Giesson procedure as described [32]. Static and
cellular histomorphometry was carried out using the OsteoMea-
sure system (Osteometrics, Decatur, USA) following the guidelines
of the American Society of Bone and Mineral Research [33]. The
cortical thickness of femora was quantified by mCT scanning using
a mCT40 (Scanco Medical, Switzerland). Femora were then tested
to failure by three-point bending on a servohydraulic device
(Z.2.5/TN1S, Zwick/Roell, Ulm, Germany) as described [34].
Sample Preparation for High-resolution Microstructure
Analysis
Bone samples were sectioned from the mid-diaphysis of femora
from 12-month-old mice. The femora were sectioned along the
tangential-longitudinal plane (Figure S1). Each half of the femoral
cortex was polished mechanically from both sides in an automatic
polisher (Logitech PM5, Logitech Ltd., Glasgow, UK) until the
sample was planar. Care was taken to make sure the samples’
longitudinal axes were parallel to the main longitudinal bone axis.
Subsequent polishing was performed using 5, 3, 1 mm grit-sized
diamond particles (DP-Spray P, Struers A/S, Ballerup, Denmark),
in that order, until the final sample thickness was 50 mm. Gross
sectioning of cortical bones was performed with a slow speed saw
(Isomet Low Speed Saw, Buehler Ltd., Lake Bluff, IL, USA) and
further processed by UV laser micro-dissection prior to spectro-
scopic and micro-mechanical probing of the tissues. The samples
were further sectioned in an UV laser micro-dissection system
(PALM MicroBeam C, P.A.L.M. Microlaser Technologies
GmbH, Bernried, Germany) [35] to isolate sections that were
150 mm (width) 650 mm (thickness) 62.5 mm (length) in di-
mension. All sectioning and micro-dissection were performed on
hydrated samples. Further detail of high-resolution microstructural
analysis is given in supporting methods appendix.
Optical Microscopy of Microstructural Features in the
Bulk Material
Macroscopic structural features in both Ahsg+/+ and Ahsg2/2
were observed with a polarized microscope (Leica DM RXA2,
Leica Microscopy and Systems GmbH, Wetzlar, Germany)
equipped with a Leica DFC digital camera. Specifically, in
reflective mode the surface of the samples were examined to
compare texture as well as osteocyte lacunae morphology and
orientation.
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Scanning Electron Microscopy of Microstructural
Features in the Bulk Material
The bulk microstructure of Ahsg+/+ and Ahsg2/2 bone was
analyzed by scanning electron microscopy (Quanta 200 ESEM,
FEI Company, Hillsboro, OR, USA) in low vacuum and a semi-
hydrated state at 3.0 kV without sputter coating. Morphologies
and orientations of the osteocyte lacunae in both Ahsg+/+ and
Ahsg2/2 bone were compared.
Confocal Laser Scanning Microscopy
Samples were stained with a rhodamine-B (Sigma-Aldrich
GmbH, Steinheim, Germany) solution diluted in a ratio of 1:5
with phosphate buffered saline (PBS) for 3 days. After washing
with PBS at neutral pH, confocal laser scanning micrographs were
obtained with a Zeiss LSM 510 scanning system (Zeiss Micro-
Imaging GmbH, Jena, Germany) equipped with a 100X oil
immersion microscope objective having a numerical aperture of
1.4. The excitation wavelength was set to 514 nm, while the
emission was measured at a range from 550 up to 650 nm. Image
stacks were measured to a penetration depth of 20 mm with each
image taken at 0.1 mm intervals. The spatial pixel resolution of
each image in the stack was 0.260.2 mm. Z-projections of image
stacks were obtained with the stddev-method plug-in of the ImageJ
image analysis package [36].
Phase Enhanced X-ray Microradiography
Representative samples from the femur of Ahsg+/+ and Ahsg2/
2, mounted in a custom made tensile tester, were imaged in the
BAMline imaging beamline of the Helmholtz Zentrum Berlin fu¨r
Materialien und Energie. Phase enhanced images were obtained
for each sample, tensed until failure, using a partially coherent and
monochromatic beam with an energy of 30 KeV. Due to Fresnel
propagation and edge enhancement, microstructural details such
as defects, cracks, and osteocytes were readily seen. Samples were
analyzed for the evolution of strain using customized software
(Labview 7.0, National Instruments, Munich, Germany) to analyze
strain along the length of the sample.
Micro-computed Tomography, mCT and Radiography
Three representative samples of sectioned femora of each
genotype were measured for their characteristic X-ray attenuation
coefficients. Samples were mounted upright on a rotation stage of
a mCT laboratory source (Skyscan 1072, Skyscan, Kontich,
Belgium) and scanned to obtain radiographs from multiple
angular orientations at an energy of 46 keV using 218 mA and
acquisition times of 2.8 seconds (pixel resolution was 1.72 mm).
Due to the parallelepiped shape of each sample, it was possible to
identify and measure radiographs of the front and side projections
corresponding to the sample widths and depths. These were used
to determine the sample dimensions (for estimates of thickness) as
well as the relative absorption of multiple regions along the sample
(relative to the regions used as background) using ImageJ [36]. In
addition, the sample dimensions were confirmed by scanning
electron micrographs of the same samples. Average sample
thickness and attenuation were determined from five measurement
points randomly collected on the sample within orthogonal sample
projections. The sample attenuation was determined with the
following equation:
m~
{ln I
I0
 
dcm
ð1Þ
where m is the attenuation coefficient, I is the intensity of the beam
passing through the sample, I0 is the empty-beam intensity without
the sample (background), and dcm is the thickness of the sample
corresponding to the attenuation measured in centimeters
(obtained from orthogonal projection).
Nanoindentation (NI) Measurements
All NI samples were embedded in polymethylmethacrylate
(PMMA) and oriented such that the tangential-longitudinal plane
was parallel to the indentation surface. The indentation surfaces
were polished with 3 and 1 mm grit-sized polishing paper and
subsequently, with 0.3 and 0.05 mm sized alumina particle
suspensions (AP-D, Struers A/S, Ballerup, Denmark). Polished
samples were mounted into a nanoindenter (Ubi 1, Hysitron Inc.,
Minneapolis, MN, USA) and indentations were performed on the
sample’s tangential-longitudinal plane using a Berkovich indenter
,10 mm2. The loading cycle for each indent consisted of 5 s
loading, 30 s holding at 5000 mN load, and 5 s unloading. All NI
measurements were performed in dry conditions. Each sample was
indented a total of 10 indents transverse to the tangential-
longitudinal plane.
Micro-tensile Mechanical Measurements
Micro-tensile experiments were performed with a custom-made
micro-tensile testing apparatus with a translation motor (M-
126.DG, Physik Instrumente, Karlsruhe, Germany) and a 250 g
load cell (ALD-MINI-UTC-250, A.L. Design Inc., Buffalo, NY,
USA) at a constant strain rate of 0.2 mm s21 to simulate quasi-
static loading. Each sectioned sample was glued to stiff teflon foils
with cyanoacrylate (Loctite Deutschland GmbH, Munich, Ger-
many) and mounted into the tensile apparatus such that the tensile
axis was parallel to the longitudinal axis of the sample. Strain
measurements were accomplished by measuring the percent
displacement between optical marks made by a 50 mm tip sized
marker (Copic Multiliner, Too Marker Products, Japan) on the
sample and tracked by a video camera (Basler A101f, Basler Vision
Technologies, Ahrensburg, Germany). Both the camera and the
tensile tester were controlled by customized software (Labview 7.0,
National Instruments). Each sample was tensed until fracture.
Stress-strain behaviors were obtained for each sample measure-
ment and further analysis were performed to determine charac-
teristic materials properties. All samples were kept hydrated during
measurements and tensed until failure.
Polarized Raman Microspectroscopy
A continuous laser beam was focused down to a micrometer
size spot on the sample through a confocal Raman microscope
(CRM200, WITec GmbH, Ulm, Germany) equipped with piezo-
scanner (P-500, Physik Instrumente, Karlsruhe, Germany). The
diode pumped linearly polarized 785 nm near infrared laser
excitation (Toptica Photonics AG, Graefelfing, Germany) was
used in combination with a water immersed 60X (Nikon, NA
= 1.0) microscope objective. For each sample, 10 different points
were analyzed. To overcome the orientation dependence of the
Raman intensity signal with respect to the orientation of the laser
polarization [37], each analyzed point was an average of 4
spectra (total integration time was 10 s) acquired with different
polarization orientations (0, 245, 45 and 90 degrees with respect
to laboratory coordinates) The spectra were acquired using an
air-cooled CCD detector (PI-MAX, Princeton Instruments Inc.,
Trenton, NJ, USA) behind a grating (300 g mm21) spectrograph
(Acton, Princeton Instruments Inc., Trenton, NJ, USA) with
a spectral resolution of 6 cm21. ScanCtrlSpectroscopyPlus
(version 1.38, WITec GmbH, Ulm, Germany) was used for the
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experimental setup and spectral processing. Raman intensities of
the Amide I band (1600–1700 cm21) and PO4
32 (910–
990 cm21) were obtained by subtracting the respective back-
ground intensity and integrating over the wave number regions
using a sum filter for each spectrum.
Scanning Electron Microscopy of Fracture Surfaces
Fracture surfaces of representative samples tensed to fracture
were imaged by scanning electron microscopy using a field-
emission scanning microscope (LEO FE-SEM Gemini 1550, LEO
Electron Microscopy Group, Oberkochen, Germany) at 3.0 kV.
Samples were sputter coated with a 3 nm uniform layer of
palladium using a sputter coater (Bal-Tec SCD-050 Cool Sputter
Coater, Bal-Tec AG, Schalksmuehle, Germany).
Lab-based Small Angle X-ray Scattering (SAXS)
Samples were measured with a laboratory-based SAXS system
(Nanostar, Bruker AXS, Madison, Wisconsin, USA) with copper
Ka radiation at 40 kV, 35 mA power settings. Each data point
represents three scan frames with an acquisition time of 1 hour.
Analysis of the data using Fit2D (AP Hammersley, ESRF,
Grenoble, France) produced a T-parameter used to evaluate the
thickness of mineral particles in the samples.
In situ Synchrotron-based SAXS
Micro-tensile measurements were performed by mounting the
custom-made microtensile apparatus in beamline ID2 at the
European Synchrotron Radiation Facility (ESRF, Grenoble,
France). Synchrotron radiation was used to measure the SAXS
patterns during microtensile measurements of hydrated samples.
Specifically, the meridional stagger D of collagen molecules in the
fibril led to an axial diffraction pattern. Percent changes in the
positions of the peaks provided measures of fibril strain while
percent changes in the positions of marks on the sample surface
provided measures of tissue strain. The fibril direction was aligned
along the tensile direction in the sample, as seen from the SAXS
images of the fibril meridional pattern (Figure S2). Subsequent
filtering of off-axis measurements were later determined during the
SAXS analysis and not included in the data.
Analysis of data involved radial integration of SAXS images
azimuthally. After integration, custom scripts were used for peak
fitting routines of the 1st order reflection from the intensity profile
of the meridional collagen SAXS pattern. An exponentially
modified Gaussian with a background term was used as a fitting
function (Figure S2).
The X-ray beam wavelength l was 0.995 A˚ and the beam
width was ,200 mm640 mm high. A FRELON 2000 CCD
detector connected to an X-ray image intensifier TTE (TH 49–
427, Thomson CSF, Moirans, France) was used for reading the
SAXS pattern. A beamstop with integrated diode was used for
normalization of the spectra to absolute scattering intensities.
SAXS frames were collected concurrently by using SPEC
(Certified Scientific Software, Boston, MA, USA) with automatic
correction for dark field current. The sample to detector distance
for the FRELON 2000 dectector was 10.0 m 63 mm measured
with linear encoder and mechanical measurement [38]. SAXS
data frames had 1,02461,024 pixels and a pixel size of
164.46164.7 mm2.
All samples were tensed to failure at a constant motor velocity of
0.2 mm s21 and SAXS measurements were collected at various
points along the stress-strain curve. Exposure time for the frames
was 0.1 s. X-ray irradiation of the sample was blocked between
exposures.
Quantitative Backscattered Electron Microscopy
The evaluation protocol of quantitative backscattered signal
intensities is based on the work of other groups and has been
described previously [39,40]. The scanning electron microscope
(LEO 435 VP, LEO Electron Microscopy Ltd., Cambridge,
England) was operated at 15 kV and 665 pA at a constant
working distance (BSE Detector, Type 202, K.E. Developments
Ltd., Cambridge, England). A pixel size of 3 mm was chosen
following the recommendation of Roschger and co-worker [41].
Mineralization profiles were generated of both cancellous bone in
the ossification zone and cortical bone of femoral and tibial
samples in each case. The degree of mineralization is presented as
the mean Ca content (mean Ca-Wt%).
Results
Normal Trabecular Bone Mass, but Reduced Length of
Long Bones in Ahsg2/2 Mice
To analyze whether fetuin-A deficiency would result in
impaired bone structure in the absence of soft tissue calcifications,
we analyzed the skeletal phenotype of 4 months old Ahsg2/2
mice that were backcrossed for 10 generations into the genetic
background C57BL/6. We first performed non-decalcified histol-
ogy on the spine followed by static histomorphometry (Fig. 1A).
Here we did not observe a significant difference between Ahsg2/2
mice and wildtype littermates in terms of the trabecular bone
volume and the trabecular number (Fig. 1B), thereby demonstrat-
ing that the osteopenia observed in Ahsg2/2 mice on a DBA/2
genetic background [25] was secondary to ectopic calcification.
This was further underscored by the fact that we observed no
significant difference in the number of bone-forming osteoblasts
and of bone-resorbing osteoclasts between wildtype and Ahsg2/2
littermates (Fig. 1C). We also did not find any gross abnormalities
in bone matrix mineralization, since the osteoid volume was not
significantly different between the two groups. The length of the
spine was also unaffected by the absence of fetuin-A. In contrast
fetuin-A deficient long bones, especially the femora were shorter
than wildtype bones (Fig. 1D). When we utilized cross-sectional
mCT scanning, we further found an increased cortical thickness of
fetuin-A deficient femora compared to wildtype controls (Fig. 1E).
This led us to perform three-point-bending assays with these
bones, where we found that the force to failure was significantly
increased for fetuin-A deficient femora (Fig. 1F). Taken together,
these results demonstrated that the absence of fetuin-A in long
bones improves their biomechanical competence, thus raising the
question, whether the intrinsic material properties of cortical bone
are altered in Ahsg2/2 mice.
Microstructure, Micromechanics as Well as Mineral and
Collagen Characteristics of Cortical Bone are Unaffected
by the Absence of Fetuin-A
Micro-structural analyses focused on homogenous bone regions
from the femoral cortex of adult mice. Typical Ahsg+/+ and
Ahsg2/2 samples observed with brightfield light microscopy
(Fig. 2A) and confocal laser scanning microscopy (Fig. 2B) revealed
no characteristic micro-structural differences. No differences were
observed in either the morphology or frequency of osteocyte
lacunae nor the canaliculae in both the Ahsg+/+ and Ahsg2/2
samples (Fig. 2A,B). Further complementing observations from
optical microscopy, scanning electron microscopy was used to
examine the microstructure in the Ahsg+/+ and Ahsg2/2 samples
(Fig. 2C). As observed in these various modes of microscopies,
both Ahsg+/+ and Ahsg2/2 samples did not display any significant
Effects of Fetuin-A Knockout on Mice Bone
PLOS ONE | www.plosone.org 4 October 2012 | Volume 7 | Issue 10 | e47338
differences in microstructure. Importantly, the micrographs
presented in Fig. 2 illustrate that the starting material for micro-
mechanical analysis was free of structural defects and preparation
artifacts.
Representative samples of the femora from Ahsg+/+ (n = 4) and
Ahsg2/2 (n = 4) mice were tested by nanoindentation. Figure 2D
shows that the elastic moduli of wildtype samples were found to be
32.560.8 GPa (mean 6 SEM), whereas the fetuin-A deficient
samples were found to be 29.060.8 GPa. The respective hardness
values were 1.2660.06 GPa in wildtype and 1.2660.04 GPa in
fetuin-A deficient bone (Fig. 2D). Thus, both the indentation
moduli and hardness values were not significantly different
between wildtype and fetuin-A deficient bone.
In addition, samples from Ahsg+/+ and Ahsg2/2 mice (n = 4 in
each case) were measured under uni-axial tension until failure in
physiologically wet conditions. A total of 10 replicate measure-
ments for each genotype were measured. Ultimate tensile strength
(UTS) values of Ahsg+/+ and Ahsg2/2 samples were found to be
44.566.2 MPa and 34.463.8 MPa, respectively. Figure 2E illus-
trates that the elastic moduli of Ahsg+/+ samples were
25.463.2 GPa (mean 6 SEM) and 16.263.1 GPa for Ahsg2/2
samples. Like the nanoindentation measurements reported in
Fig. 2D, the tensile moduli and UTS of wildtype and and fetuin-A
deficient bone samples were not statistically different from each
other (p= 0.11 and p= 0.33 for tensile modulus and UTS,
respectively) suggesting that the bone materials properties of these
bone samples were very similar at the micro-scale. Figure 2F shows
representative fractured samples from micro-mechanical tensile
measurements examined by scanning electron microscopy to
visualize the fracture surfaces. Samples from both Ahsg+/+ and
Ahsg2/2 mice showed virtually indistinguishable fracture sur-
faces, which are typical of brittle fractures. At higher magnifica-
tions, both Ahsg+/+ and Ahsg2/2 bone showed collagen fiber
bundles with similar orientations and structure (Fig. 2F inset).
Indeed, micro-mechanical testing validates that the bone material
in wildtype and Ahsg2/2 mice is very similar despite the clear
difference at the macro-scale in mechanical strength and the
slightly elevated mineral content of whole fetuin-A deficient bone
(Fig. S3).
Polarized Raman micro-spectroscopy was performed to de-
termine the chemical composition of cortical bone to reveal
differences in organic to mineral compositions as shown in Fig. 3A
[37]. Absolute intensities of the mineral peak (PO432) were
normalized to intensities of the Amide I peak to obtain
a normalized ratio of mineral to organic in each sample. The
mean relative ratio was 9.8060.194 for Ahsg+/+ samples and
Figure 1. Normal trabecular bone mass, but increased cortical bone strength in fetuin-A deficient mice. (A) Von Kossa/van Gieson-
stained undecalcified sections of the spine from 4 months old wildtype and fetuin-A deficient mice. (B) Histomorphometric quantification of the
trabecular bone volume (BV/TV, bone volume per tissue volume) and the trabecular number (Tb.N.). (C) Histomorphometric quantification of the
osteoblast number (N.Ob./B.Pm, number of osteoblasts per bone perimeter) and the osteoclast number (N.Oc./B.Pm, number of osteoclasts per bone
perimeter). (D) Contact radiographs of the hindlegs from 4 months old Ahsg+/+ and Ahsg2/2 mice. The femoral length is given below. (E) Cross-
sectional mCT scanning of the femora. (F) Quantification of the cortical thickness and the force to failure in three-point-bending assays. All values
represent mean6SD (n = 8 per group). Asterisks indicate statistically significant differences (p,0.05).
doi:10.1371/journal.pone.0047338.g001
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9.5660.27 for the Ahsg2/2 samples, respectively (Fig. 3B).
ANOVA statistical evaluation of the ratios between the Ahsg+/+
and Ahsg2/2 sample groups showed no statistically significant
differences (P = 0.46 for the PO4/Amide I).
To further validate the degree of mineralization found in
Raman spectroscopy, X-ray attenuation and absorption experi-
ments were performed to compare the differences between
fetuin-A deficient and wildtype samples (Fig. 3B). Micro-
computed tomography revealed for Ahsg+/+ samples an atten-
uation coefficient of 47.061.7 cm21 (mean 6 SEM), whereas
Ahsg2/2 samples had a mean value of 46.063.2 cm21. Judged
by one-way ANOVA statistics, the attenuation coefficients of
Ahsg+/+ and Ahsg2/2 samples were not significantly different
(p= 0.36). Likewise in a laboratory based X-ray scattering
experiment, the X-ray beam absorption, which is a measure of
X-ray density was similar in Ahsg+/+ and Ahsg2/2 samples.
Additional analysis provided a T-parameter derived from the
scattering data to describe the dimensions of the mineral
crystallites in the Ahsg+/+ and Ahsg2/2 samples. The T-
parameter derived from the scattering data were very similar in
that 2.15 nm 60.05 were calculated for Ahsg+/+ samples and
2.19 nm 60.09 for the Ahsg2/2 samples (n = 10, p= 0.06).
Using in situ micro-tensile measurements coupled with
synchrotron diffraction, the behavior of the mineralized collagen
fibrils was examined with respect to the deformation occurring at
the tissue level. In the SAXS regime of reciprocal space, the D
period of collagen molecules in the fibril was measured and the
deformation in each sample was tracked by following the positions
of the diffraction peaks which allowed for a measurement of the
collagen fibril strain. When normalized with respect to the tissue
strains of the sample, we found little differences in strain between
the populations of Ahsg+/+ and Ahsg2/2 samples (Fig. 3C). We
observed that the tissue strains in both Ahsg+/+ and Ahsg2/2
samples occurred within a small range of 0–0.2% before failure.
No plastic deformation was observed in either sample types before
failure. The normalized fibril-tissue strains of mouse bone samples
regardless of the Ahsg genotype were usually
efibril
etissue
w1:0. This
suggested that deformation behaviors of the fetuin-A deficient and
wildtype mice samples were similar.
We did not detect differences in the microstructure of fetuin-A
deficient bone that would explain the increased mechanical
strength determined by macro-scale mechanical testing. The
striking length difference between wildtype and Ahsg2/2 bones
could also not be explained by microscale compositional
Figure 2. Microstructural and micro-scale mechanical properties of Ahsg+/+ and Ahsg2/2 cortical bone. (A). Light microscopy of
osteocyte lacunae in Ahsg+/+ and Ahsg2/2 samples, respectively (scale bar: 20 mm) (B). Laser scanning confocal microscopy using Rhodamine-B as
a contrasting agent showing osteocytic and canalicular networks in Ahsg+/+ and Ahsg2/2 samples, light areas are intensely stained with
Rhodamine-B, scale bar: 20 mm. (C) Backscatter scanning electron microscopy revealing the microstructure at the surface and no significant
differences in density, scale bar: 10 mm. (D) Nanoindentation (n = 80) measurements of the indentation moduli and hardness of Ahsg+/+ and Ahsg2/
2 bone samples (E) Micro-tensile (n = 20) measurements of tensile strength and elastic moduli in wildtype and fetuin-A deficient bone samples (F)
Representative Ahsg+/+ and Ahsg2/2 fracture surfaces showing evidence of brittle failure, scale bar: 20 mm, inset: higher magnification of the
fracture surface, scale bar: 2 mm.
doi:10.1371/journal.pone.0047338.g002
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differences. Failure to detect clear differences in bone cellularity
effectively ruled out bone cell dysregulation as a likely cause for the
shorter femora. Likewise the differences in total bone mineral
could not be accounted for by the microscale composition
determined by the aforementioned X-ray and Raman spectro-
scopic measurements.
Increased Mineral Content in the Growth Plates of
Fetuin-A Deficient Long Bones
Since a reduced femoral length can also explain the increased
biomechanical competence in bending of fetuin-A deficient
femora, we next analyzed the growth plate cartilage in these
mice. The ossification zone in growth plates of wildtype tibia and
femora shown in Fig. 4A revealed the appearance of cartilage
cores in the primary and secondary trabeculae indicating a non-
completed cartilage-to-bone transition at age 4 months. This is in
contrast to the Ahsg2/2 growth plates, which showed a completed
bone mineralization without the occurrence of cartilage cores
within the trabeculae. Similarly the analysis of Ahsg2/2 distal
femur growth plates revealed more mineralized bridges per growth
plate than wildtype (4.061.4 vs. 1.660.5, n = 6, p = 0.009)
suggesting more complete growth plate mineralization and closure
(Fig. S4). Furthermore, differences between wildtype and Ahsg2/
2 mice were obvious with regard to the growth plate chondrocyte
organization (Fig. 4A). Ahsg2/2 mice had discontinuities across
the growth plates and regions of thickened calcified bridge
formations (Fig. 4A) as observed by backscattered electron
microscopy from the bisection in mineralized and non-mineralized
tissue (Fig. 4B). The quantification of backscattered signal
intensities showed that the mineral content in Ahsg2/2 mice
was significantly increased in both tibial and femoral growth plates
in comparison to Ahsg+/+ mice (Fig. 4C). This difference between
Ahsg2/2 and Ahsg+/+ mice was restricted to the measured
calcified growth plates since the cortical counterparts showed no
comparable difference in the degree of mineralization (Fig. 4D).
Focusing on the inter-site differences in femoral and tibial regions
of interest both Ahsg2/2 and Ahsg+/+ showed increased calcium
content in the femoral growth plates and cortices (Fig. 4 C,D).
In summary, the observed increase in macroscale mechanical
bending strength of the fetuin-A deficient bone was most likely due
to stunted growth caused by increased or premature growth-plate
cartilage mineralization. This also corresponds to the associated
overall shorter length, increased cortical thickness and slightly
increased bone diameter at the midshaft position found in the
skeletal tissues. Collectively, these changes resulted in macroscop-
ically stronger femora and tibia in fetuin-A deficient mice than in
wildtype adult mice, despite similar microscopic properties of the
bone material.
Discussion
Fetuin-A/Ahsg content had little effect on bone mineral or
matrix quality in the cortex, instead it dramatically affected the
growth plate morphology. Femora from fetuin-A deficient mice
were approximately 30% shorter than in age-matched wildtype
mice (Fig. 1). This phenotype of Ahsg2/2 mice signifies a form of
mineralization dependent dysplasia that had previously gone
unnoticed. An earlier study of Ahsg2/2 mice maintained on
a mixed genetic background of 129SvJ/B6, likewise reported
shorter long bones in the null mutants [24], but missed two
features presented here. Firstly, we determined that the fore-
shortening was associated with increased mineralization restricted
to the growth plate chondrocytes. Additionally, the remainder of
the bone material was structurally and mechanically equivalent to
Figure 3. Mineral and organic components in Ahsg+/+ and
Ahsg2/2 femoral cortical bone. (A) A typical Raman spectrum of
representative Ahsg+/+ and Ahsg2/2 samples with peaks at 910–
990 cm21 and 1600–1700 cm21 representing PO4
32 (mineral) and
Amide I (organic matrix) groups, respectively. inset: Normalized
intensity measurements at polarization angles of 245, 0, 45, 90 were
made to address the orientation artifacts of Raman intensity of type I
collagen for both Ahsg+/+ and Ahsg2/2. The dashed lines are fits
which estimate parameters characteristic of sample orientation and
mineralization. The solid lines indicate mean intensity values of
mineralization in the samples. (B) The mineral content normalized with
the organic matrix can be observed by Raman ratios between Ahsg+/+
and Ahsg2/2 samples. Further complementing these observations,
measurements of the mineral component were made with X-ray
attenuation, absorption, as well as small-angle X-ray scattering. (C)
Comparing fibrillar versus tissue strains in Ahsg+/+ (green circles) and
Ahsg2/2 (red squares) bone. Samples were measured with in-situ
synchrotron small angle X-ray scattering to determine the amount of
strain contributed by the collagenous fibrils within the Ahsg+/+ and
Ahsg2/2 samples. Dashed lines represent orientation guides.
doi:10.1371/journal.pone.0047338.g003
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wildtype bone. Here, we reconcile the fetuin-A deficient bone
phenotype with the well-established role of fetuin-A as a potent
systemic inhibitor of mineralization [9,11,13,15,20,25,27,42,43]
and offer a simple, straightforward explanation for the observed
long bone growth defect–we propose that the stunted growth is
a consequence of premature growth plate mineralization. The role
of fetuin-A activity as a regulator of mineralization of hypertrophic
chondrocytes in the growth plate fits well with its tissue
distribution. Growth plate cartilage is free of fetuin-A, because it
is not vascularized. Vascularization and blood supply enter at
a time when mineralization commences, a process highly
controlled by molecular inhibitors to regulate the kinetics of
mineralization. Any change in fetuin-A concentration at this
critical time translates into noticeable changes in mineralization in
solution, a biochemical process studied in great detail by us
[8,9,11,44–47] and others [10,12,14,15,29,30,48,49]. Endochon-
dral ossification represents the culmination of a sequence of
changes in the cartilage cells and their associated matrix that must
always occur in the same order and requires a minimum period of
time [50]. The developmental regulation of the growth plate
progresses from the condensation of mesenchymal cells, their
differentiation into chondrocytes and finally maturation to matrix-
secreting hypertrohic chondrocytes that cross-talk to the bone
collar and attract blood vessels. Ultimately the hypertrophic
chondrocytes undergo apoptosis and mineralize [51]. Our results
indicate that the lack of fetuin-A, a serum borne inhibitor of
mineralization may accelerate the final step of this process, namely
matrix mineralization, thus prematurely terminating growth plate
activity and longitudinal bone growth. It is presently unclear, why
only the proximal long bones are shorter. There is however,
a striking phenocopy of fetuin-A deficieny. Physeal obliteration in
humans [52] and the so-called hyena disease in calves [53] are
caused by vitamin A-induced premature closure of epiphyses that
cause preferential foreshortening of hind limb bones. Vitamin A/
retinoic acid is thought to accelerate the progression of
chondrocytes from the proliferative phase to the calcifying stage
Figure 4. Growth plate morphology and mineralization in Ahsg+/+ and Ahsg2/2 mice. (A) Wildtype mice had dark blue stained cartilage
cores within metaphyseal trabeculae of the growth plates, whereas Ahsg2/2 had completed the cartilage-to-bone transition without the remains of
cartilage cores within the trabeculae. Moreover, Ahsg 2/2 mice showed pronounced discontinuities in the chondrocyte column organization in
comparison to the wildtype mice (Toluidine blue staining). (B) Ahsg 2/2 mice frequently showed thickened calcified bridge formations across their
growth plates, which was confirmed by backscattered electron microscopy. The orange and black areas correspond to mineralized and non-
mineralized tissue, respectively. (C) The mineral content in Ahsg2/2 mice was significantly increased in both tibial and femoral growth plates in
comparison to wildtype mice as judged by quantitative backscattered electron imaging. (D) In contrast, the mineralization (mean Ca Wt%) of the
femoral and tibial cortices was similar in Ahsg2/2 and Ahsg+/+ mice.
doi:10.1371/journal.pone.0047338.g004
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bypassing hypertrophy and thus bone length growth. A role of
fetuin-A in the regulation of vitamin A bioavailability and activity
merits further study.
Fetuin-A and the human homologue, a2-HS glycoprotein, induce
alkaline phosphatase in epiphyseal growth plate chondrocytes [54].
The induction of this maturation marker may represent an adaptive
response in the presence of surplus mineralization inhibitor,
triggering the natural chondrocyte progression into mineralized
cartilage. In fact, the growth plate chondrocytes may be the cell type
that is physiologically most prone to pathological mineralization,
because it grows in an environment well protected from mineral
supply and thus mineralization, yet becomes quickly exposed to
a mineralizing fluid once the cartilage is vascularized. It will be
interesting to revisit the influence of fetuin-A on physiological
chondrocyte mineralization in a similar way previously performed
withprimaryosteoblasts [8]andsmoothmusclecells [42]asmodelsof
physiological and pathological mineralization, respectively.
Our results show that fetuin-A has a developmental rather than
a structural role in murine bone. Fetuin-A is known to hinder the
precipitation of calcium phosphate in blood serum and sub-
sequently, prevents ectopic calcification of soft tissues. Clearance
of fetuin-A containing protein-mineral complexes by the mono-
cytic phagocyte system efficiently prevents local depostion [55].
Patients suffering from chronic kidney disease show decreased free
serum fetuin-A and increased serum fetuin-A mineral complexes
[17], which can be quantified by a nanoparticle-based serum test
measuring overall calcification inhibition [56]. The influence of
fetuin-A in initial bone mineralization seems, however, minimal in
the present model, despite the fact that fetuin-A is deposited in
mineralized bone in large amounts [4–7].
Supporting Information
Figure S1 Schematic of sample preparation. (A). Femora
of mice were sectioned along the anteriorposterior axis (as seen by
micro-CT) scale bar: 3 mm (B). Cortical bone from the mid-
diaphysis of each sample were further sectioned (C). Sectioning
and polishing along the longitudinal-tangential plane (D). Laser
microdissection was used to further section the sample into
dimensions of 2.5 mm60.05 mm60.15 mm (as seen by phase
enhanced X-ray radiography) scale bar: 75 mm.
(TIF)
Figure S2 Determining the fibrillar strain from SAXS
measurements. (A) Image of the meridional collagen SAXS
pattern from Fit2D (B) Radial integration of the meridional
collagen pattern produces an intensity profile with respect to Q-
space showing the 1st, 2nd, and 3rd order reflections (C) Fibrillar
strain can be measured from the percent change in position of the
1st order peak as reflected in the SAXS patterns during in situ
tensile measurements.
(TIF)
Figure S3 Tibia morphology and mineralization in
wildtype (Ahsg +/+) and fetuin-A deficient (Ahsg2/2)
mice. The mean calcium content in tibias of Ahsg 2/2 mice was
increased in comparison to wildtype mice as judged by
quantitative backscattered electron imaging of the enlarged areas
shown in the middle panels. Ash weight of tibia halves (shown in
the top panels) was also increased in Ahsg 2/2 mice compared to
wildtype mice. n = 4; * p,0.05; ** p,0.01.
(TIF)
Figure S4 Distal femur growth plate morphology and
mineralization in wildtype (A, C, E) and fetuin-A
deficient (B, D, F) mice. These representative samples show
higher numbers of bone bridges and more mineralization in the
growth plate of fetuin-A deficient mice than wildtype mice.
(TIF)
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